Back to FDA Applications sponsored by VALEANT PHARMS NORTH

FDA Drug Application 021271 by VALEANT PHARMS NORTH

Application Number021271
Application Type New Drug Application
Sponsor ApplicantVALEANT PHARMS NORTH
Most Recent Label Available Flag
Current Patent Flag
Action Type Approval
Chemical Type New ester, new salt, or other noncovalent derivative
Therapeutic Potential Standard
Orphan Code 


  
Action TypeDuplicate CounterAction DateDocument TypeApplication Document IDSequence NumberDocument TitleDocument URLDocument Date
AP04/4/2003N4923000   http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/021271lbl.pdf 4/7/2003
AP04/4/2003N5388000   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/21271ltr.pdf 4/18/2003
AP04/4/2003N10647000   http://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21-271_Iprivask.cfm 11/22/2004
AP07/1/2014SCM       
AP011/7/2014SLR40974006   http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021271s006lbl.pdf 11/10/2014
AP011/7/2014SLR40980006   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/021271Orig1s006ltr.pdf 11/12/2014
AP05/18/2015SCM       




Back to FDA Applications sponsored by VALEANT PHARMS NORTH